Submitted by Anonymous (not verified) on 13 October 2023 - 9:57
Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, HIV Infections, Date of authorisation: 17/12/2020, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, HIV Infections, Date of authorisation: 17/12/2020, Revision: 9, Status: Authorised